Hypera-Takeda deal assigned to CADE Tribunal councilor Azevedo, Tupy-Teksid assigned to Braido
MLex Summary: Hypera's planned buyout of certain medicines from Takeda Pharmaceuticals International has been assigned to Brazilian competition authority Tribunal Councilor Paula Farani de Azevedo Silveira, following the Superintendence's opinion that the...To view the full article, register now.
Already a subscriber? Click here to view full article